Exane Derivatives’s Ecolab ECL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.31K Sell
15
-774
-98% -$128K ﹤0.01% 426
2022
Q1
$139K Sell
789
-115
-13% -$21.6K 0.04% 419
2021
Q4
$212K Sell
904
-256
-22% -$57.9K 0.05% 324
2021
Q3
$242K Sell
1,160
-1,718
-60% -$377K 0.06% 346
2021
Q2
$612K Buy
2,878
+1,563
+119% +$340K 0.14% 147
2021
Q1
$282K Buy
+1,315
New +$280K 0.08% 235
2019
Q3
Sell
-1,301
Closed -$257K 666
2019
Q2
$257K Buy
1,301
+1,300
+130,000% +$242K 0.05% 235
2019
Q1
$176 Sell
1
-704
-100% -$114K ﹤0.01% 571
2018
Q4
$104K Hold
705
0.02% 319
2018
Q3
$110K Sell
705
-29
-4% -$4.3K 0.02% 307
2018
Q2
$104K Sell
734
-87
-11% -$12.5K 0.02% 330
2018
Q1
$111K Buy
821
+17
+2% +$2.29K 0.02% 290
2017
Q4
$108K Buy
804
+67
+9% +$8.91K 0.02% 288
2017
Q3
$94.8K Buy
737
+79
+12% +$10.4K 0.02% 268
2017
Q2
$87.3K Sell
658
-6,044
-90% -$781K 0.02% 285
2017
Q1
$840K Buy
+6,702
New +$819K 0.19% 94

Other funds holding ECL

Exane Derivatives's ECL Position: Q2 2022 in Review

Exane Derivatives reduced its Ecolab (ECL) stake by 98% in Q2 2022, selling an estimated $128K and leaving 15 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Exane Derivatives first reported a position in ECL in Q1 2017 and has held it in 16 quarters since. The position peaked at $840K in Q1 2017. 1,211 funds tracked by Wall St. Rank hold ECL as of Q2 2022.

  • Exane Derivatives held 15 shares of Ecolab worth $2.31K as of Q2 2022.
  • Exane Derivatives sold 774 Ecolab shares in Q2 2022, an estimated $128K.
  • Ecolab made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #426 holding.
  • Exane Derivatives first reported a position in Ecolab in Q1 2017 and has held it in 16 quarters since.
  • Exane Derivatives's Ecolab position peaked at $840K in Q1 2017.
  • 1,211 funds tracked by Wall St. Rank held Ecolab as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.